Idea or Concept
Annovis says ‘data cleaning’ postpones buntanetap readout in Parkinson’s
buntanetap, Annovis, Parkinson’s
Sarepta shares PhII data for next-gen exon skipping drug, but regulatory pathway is unclear
Regulatory Pathway, Sarepta, next-generation exon-skipping drug, United States Food and Drug Administration, Approved, Muscular Dystrophy, Duchenne, gene therapy, Sarepta’s gene therapy